Clinical trials
Thrombosis clinical trials
Below are recruiting thrombosis clinical trials, each written for real people, not researchers. We’re tracking 173 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06857838Recruiting
Bypass surgery for symptomatic myocardial bridge
This trial tests whether bypass surgery is effective for people with a myocardial bridge (a heart muscle that arches over an artery) that still causes symptoms despite medication. It aims to see if surgery can improve symptoms and outcomes.
Xi'an, ShaanxiAges 18–80 - NCT07327788RecruitingPhase 2
Study of QL1706, bevacizumab, and chemo infusion for liver cancer with portal vein clot
This trial tests a combination of three treatments for people with advanced liver cancer that has spread into the main portal vein. The goal is to see if this therapy can shrink tumors and improve outcomes.
Guangzhou, GuangdongAges 18 years+ - NCT07322978Recruiting
Blood Clots in Veins of the Gut During Pancreatitis
This study looks at how often blood clots form in veins near the gut (called splanchnic venous thrombosis) in people with acute pancreatitis. It also checks if the clots are linked to how severe the pancreatitis is. The goal is to help doctors better understand and possibly prevent these clots.
Hyderabad, TelanganaAges 18–85 - NCT07301892Recruiting
AI help for rheumatoid arthritis diagnosis
This trial tests whether artificial intelligence (AI) can improve how doctors spot complications in people newly diagnosed with rheumatoid arthritis (RA), a condition that causes joint pain and swelling. The goal is to see if AI can make diagnosis faster and more accurate in real-world hospital settings.
Beijing, Beijing MunicipalityAges Any age - NCT06880978Recruiting
Comparing two stent methods for Y-shaped heart blockages
This study compares two stent-placing techniques for people with a specific type of complex heart blockage at a branch point. It aims to see which method is safer and more effective for opening up the artery.
IstanbulAges 18 years+ - NCT05711173Recruiting
Study blood clot triggers and immune cell changes in clot patients
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
BordeauxAges 6–50 - NCT06198816Recruiting
Ultrasound and balloon treatment for old leg clots
This study tests a new way to treat long-standing blood clots in the leg using ultrasound waves and a balloon procedure. It aims to improve blood flow and reduce symptoms like swelling and pain for people who haven't gotten better with standard treatments.
Milan, ItalyAges 18–75 - NCT07196020Recruiting
Predicting blood clots during chemotherapy for certain cancers
This study looks at whether doctors can predict blood clots in people with certain cancers who are receiving chemotherapy. If you have ovarian, lung, stomach, or pancreatic cancer and are starting chemotherapy, you may be able to join and help improve clot prevention.
Cork, IrelandAges 18 years+ - NCT06949319Recruiting
Stroke Risk and Blood Clots in New Atrial Fibrillation
This study looks at stroke risk and blood clotting in people who have just been diagnosed with atrial fibrillation (AFib) that is not caused by a heart valve problem, and who have not yet taken blood thinners. It aims to better understand how blood clots form in this condition.
Esbjerg, Region SyddanmarkAges 18 years+ - NCT07166731Recruiting
Carotid stent vs. medication for recent stroke risk
This trial tests if a carotid artery stent plus medication is better than medication alone at preventing another stroke in people who recently had a stroke or eye blockage caused by a non-narrowing but risky carotid plaque.
Solingen, North Rhine-WestphaliaAges 18 years+ - NCT07137429Recruiting
Platelet donor long-term health study
This study looks at healthy adults who donate platelets to understand how platelets change over time. You must fast before blood draws and avoid certain medicines like aspirin or ibuprofen for a week before each visit.
Bethesda, MarylandAges 18–100 - NCT07142343RecruitingPhase 4
Testing pozelimab safety in young children with CHAPLE disease
This trial tests if pozelimab is safe for children aged 1 to 5 with CHAPLE disease, a rare condition that causes swelling, blood clots, and protein loss. If your child has active CHAPLE disease, this study may offer a new treatment option.
IstanbulAges 1–5 - NCT07140211RecruitingPhase 3
Low-dose heparin to prevent blood clots after childbirth
This trial is testing a short course of a low-dose blood thinner (heparin) to prevent dangerous blood clots in the legs or lungs after childbirth. It is for women who have certain risk factors that make clots more likely.
BadenAges 18 years+ - NCT07132515RecruitingPhase 4
Blood thinners for cirrhosis with portal vein clot
This study tests whether blood thinners (anticoagulants) are safe and effective for people with cirrhosis and a blood clot in the portal vein. It may also include people with liver cancer (HCC).
Al Mansurah, Dakahlia GovernorateAges 18–70 - NCT07122089RecruitingPhase 2
SIRT plus immunotherapy for liver cancer with portal vein clot
This trial tests a two-step approach for liver cancer that has spread into the portal vein. First, you receive internal radiation (SIRT) to shrink the tumor, followed by immunotherapy drugs (durvalumab with or without tremelimumab) to help your immune system fight the cancer. The goal is to see if this combination is safe and effective.
GrenobleAges 18 years+ - NCT07119970Recruiting
NETosis markers for predicting blood clots in MPN
This study looks at certain markers in the blood to see if they can predict blood clots in people with myeloproliferative neoplasms (MPN) like polycythemia vera, essential thrombocythemia, or pre-myelofibrosis. It is only for people who have a specific JAK2 mutation and are at high risk for clots, and who are already enrolled in another trial and a biobank.
AngersAges 18 years+ - NCT07098676Enrolling by invitation
How dialysis affects blood clotting in kidney patients
This trial looks at how hemodialysis changes blood clotting in dialysis patients. It may help doctors understand why some people form clots and how to prevent them.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT07102160Recruiting
Long-term safety and effectiveness of the Cleaner Vac system for blood clots
This study tracks how well the Cleaner Vac® system works to remove blood clots from leg veins over time. It may be an option for people with new or recent deep vein thrombosis (DVT) who are getting their first treatment.
Fort Lauderdale, FloridaAges 18 years+ - NCT03255928Recruiting
Study blood clot cell activity in people with a heart pump
This study looks at how your blood’s clot-forming cells (platelets) behave when you have a heart pump device placed (short-term or long-term). The results may help doctors better understand complications and how to manage them after implantation.
Milan, MIAges 18–75 - NCT03855592Recruiting
Cancer patients with blood clots: thrombosis and cancer registry
This study is a registry that collects information about blood clot events in people with cancer. The goal is to better understand how often clots happen and what patterns they follow, which can help improve care.
Alcoy, AlicanteAges 18 years+ - NCT06519292Recruiting
Heart side effects from immunotherapy in cancer patients
This trial looks at whether immunotherapy drugs (checkpoint inhibitors) cause heart problems in people with certain cancers. It will help doctors understand who is at risk and how to monitor for side effects.
Amsterdam, North HollandAges 50 years+ - NCT06989255Recruiting
Ultrasound image collection study for DVT research
This study collects ultrasound images from people who need a DVT test. The goal is to create a data set for research that may improve how DVT is diagnosed.
MontmorencyAges 18 years+ - NCT06523959RecruitingPhase 4
Blood clot prevention in abdominal or pelvic surgery
This trial tests whether a medication called apixaban (a blood thinner) can safely prevent blood clots after abdominal or pelvic surgery. It is for people who have a moderate risk of clots and bleeding, and who are not taking other blood thinners.
HelsinkiAges 18 years+ - NCT07009873Recruiting
Wearable ultrasound sensor trial for heart, leg, or ICU patients
This trial tests a wearable ultrasound sensor that can be stuck to the skin to monitor your heart, leg blood clots, or vital signs in the ICU. It may replace bulky machines and let doctors see your condition more easily and continuously.
Beijing, Beijing MunicipalityAges 18–70
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for thrombosis?
- Yes. Clin2 currently lists 173 recruiting thrombosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a thrombosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a thrombosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.